Prokidney (PROK) Treasury Shares (2021 - 2026)
Prokidney's (PROK) quarterly Treasury Shares came in at $10089.0 in Q1 2026, down 98.71% year-on-year from $779856.0 in Q1 2025, and down 98.62% on a QoQ basis from $733252.0 in Q4 2025.
Prokidney (PROK) Treasury Shares (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Treasury Shares data on file, last reported at $10089.0 in Q1 2026.
- On a quarterly basis, Treasury Shares fell 98.71% year-over-year to $10089.0 in Q1 2026; TTM through Mar 2026 was $10089.0, a 98.71% decrease from a year earlier, with the FY2025 full-year figure at $733252.0, down 58.24% from the prior year.
- Treasury Shares for Q1 2026 stood at $10089.0, down from $733252.0 in the prior quarter.
- Over the last five years, Treasury Shares for PROK reached as high as $25.0 million in Q1 2022 and fell as low as $10089.0 in Q1 2026.
- Historically, Treasury Shares has averaged $5.9 million across 5 years, with a median of $2.3 million in 2024.
- Across the five-year window, Treasury Shares surged 315.18% in 2022 and slumped 98.71% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $8.4 million in 2022, then slumped by 57.4% to $3.6 million in 2023, then sank by 50.76% to $1.8 million in 2024, then plunged by 58.24% to $733252.0 in 2025, then tumbled by 98.62% to $10089.0 in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $10089.0 in Q1 2026, $733252.0 in Q4 2025, and $740933.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | 10,089.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,089.00 |
| Mar 31, 2026 | 10,089.00 |
| Dec 31, 2025 | 733,252.00 |
| Dec 31, 2025 | 733,252.00 |
| Sep 30, 2025 | 740,933.00 |
| Sep 30, 2025 | 740,933.00 |
| Jun 30, 2025 | 742,684.00 |
| Jun 30, 2025 | 742,684.00 |
| Mar 31, 2025 | 779,856.00 |
| Mar 31, 2025 | 779,856.00 |
| Dec 31, 2024 | 1.76 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 3.57 Mn |
| Dec 31, 2023 | 3.57 Mn |